Radotinib(IY-5511)Bcl-Abl tyrosine kinase inhibitor CAS# 926037-48-1 |
- Laminin (925-933)
Catalog No.:BCC1015
CAS No.:110590-60-8
- Epidermal Growth Factor Receptor Peptide (985-996)
Catalog No.:BCC1014
CAS No.:96249-43-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 926037-48-1 | SDF | Download SDF |
PubChem ID | 16063245 | Appearance | Powder |
Formula | C27H21F3N8O | M.Wt | 530.5 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | >26.6mg/mL in DMSO | ||
Chemical Name | 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide | ||
SMILES | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=NC=CN=C5 | ||
Standard InChIKey | DUPWHXBITIZIKZ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Radotinib(IY-5511) Dilution Calculator
Radotinib(IY-5511) Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.885 mL | 9.4251 mL | 18.8501 mL | 37.7003 mL | 47.1254 mL |
5 mM | 0.377 mL | 1.885 mL | 3.77 mL | 7.5401 mL | 9.4251 mL |
10 mM | 0.1885 mL | 0.9425 mL | 1.885 mL | 3.77 mL | 4.7125 mL |
50 mM | 0.0377 mL | 0.1885 mL | 0.377 mL | 0.754 mL | 0.9425 mL |
100 mM | 0.0189 mL | 0.0943 mL | 0.1885 mL | 0.377 mL | 0.4713 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Radotinib(IY-5511) is a novel and selective Bcl-Abl tyrosine kinase inhibitor. [1]
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
In vitro, radotinib couples to Bcr-Abl and reduce the phosphorylation of Bcr-Abl target protein CrkL. The pre-clinical studies shows superiority of radotinib to imatinib in both wild-type and mutant BCR-ABL1 positive CML cell lines. [1]
In a phase I clinical trial, dose up to 1000 mg/day of radotinib exhibits no dose-limiting toxicities. Phase II study proves radotinib to be an effective and well tolerated in chronic phase-chronic myeloid leukemia patients with resistance and/or intolerance to Bcr-Abl1 tyrosine kinase inhibitors. [1]
Reference:
1. Kim SH, Menon H, Jootar S et al. Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. Haematologica. 2014 Jul;99(7):1191-6.
- AMTB hydrochloride
Catalog No.:BCC7834
CAS No.:926023-82-7
- Dayecrystal A
Catalog No.:BCN4859
CAS No.:926010-24-4
- Secaubrytriol
Catalog No.:BCN4468
CAS No.:925932-10-1
- Secaubryenol
Catalog No.:BCN4467
CAS No.:925932-08-7
- TG100713
Catalog No.:BCC4985
CAS No.:925705-73-3
- 3-Isomangostin hydrate formate
Catalog No.:BCN4466
CAS No.:925705-36-8
- Acitretin sodium
Catalog No.:BCC4299
CAS No.:925701-88-8
- KU-60019
Catalog No.:BCC3699
CAS No.:925701-49-1
- 10-DEBC hydrochloride
Catalog No.:BCC7409
CAS No.:925681-41-0
- Jingzhaotoxin III
Catalog No.:BCC6327
CAS No.:925463-91-8
- Viscidulin I
Catalog No.:BCN4465
CAS No.:92519-95-4
- Viscidulin II
Catalog No.:BCN3187
CAS No.:92519-93-2
- O-Demethylforbexanthone
Catalog No.:BCN4469
CAS No.:92609-77-3
- Milnacipran
Catalog No.:BCC4194
CAS No.:92623-85-3
- BG45
Catalog No.:BCC6469
CAS No.:926259-99-6
- GGsTop
Catalog No.:BCC6187
CAS No.:926281-37-0
- Deltatsine
Catalog No.:BCN8106
CAS No.:92631-66-8
- Germacrone 4,5-epoxide
Catalog No.:BCN6724
CAS No.:92691-35-5
- Toll-like receptor modulator
Catalog No.:BCC2007
CAS No.:926927-42-6
- Motolimod (VTX-2337)
Catalog No.:BCC6497
CAS No.:926927-61-9
- Glochicoccin D
Catalog No.:BCN4471
CAS No.:927812-23-5
- KC7F2
Catalog No.:BCC2434
CAS No.:927822-86-4
- DPNI-caged-GABA
Catalog No.:BCC5957
CAS No.:927866-58-8
- RAF265
Catalog No.:BCC3677
CAS No.:927880-90-8